Verrica Pharmaceuticals buy Royal Bank of Canada
Start price
18:00
/
50%
€1.27
Target price
04.10.25
€10.03
Performance (%)
-5.18%
Price
03.10.24
€0.99
Summary
This prediction is currently active. With a performance of -5.18%, the BUY prediction for Verrica Pharmaceuticals by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 04.10.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Verrica Pharmaceuticals | -5.18% |
iShares Core DAX® | -1.471% |
iShares Nasdaq 100 | -0.486% |
iShares Nikkei 225® | -2.115% |
iShares S&P 500 | 0.394% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for VRCA provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.60
15.08.24
15.08.24
€11.83
15.08.25
15.08.25
-53.58%
03.10.24
03.10.24